Healthcare Big Data Risk Control Provider "Zhanlü Data" Closes Nearly RMB 100 Million Series B Round

Recently, Shanghai-based insurtech company Zhanlue Data (hereinafter referred to as "Zhanlue Data") announced the completion of a nearly 100 million yuan Series B funding round. This round was led by Lingfeng Capital, with follow-on investments from PPDai and other investors.

Zhanlue Data is a technology company focused on health insurance risk control, serving insurance payers by providing enterprise-level big data risk control solutions for commercial insurance companies and insurance intermediaries. Its founding team members come from top-tier Silicon Valley tech companies, and its core team comprises technology experts, insurance business specialists, and healthcare professionals.

Founded in 2016, Zhanlue Data immediately secured angel investment from Gaorong Ventures, Fumu Asset, and Silicon Valley investor Wei Guo. In 2017, the company completed its Series A round with participation from DCM, Puhua Capital, Qihoo Zhongcai, Gaorong Ventures, and Fumu Asset. The company currently maintains dual headquarters in Beijing and Shanghai, with branch offices in Nanjing, Hangzhou, Chengdu, Changsha, Guangzhou, Shenzhen, and other cities. In 2019, Zhanlue Data established its international headquarters in Hong Kong, focusing on expanding across Asian markets.

In recent years, regulators have issued multiple guidance documents and policies for the insurance industry, gradually shifting from "promoting growth" to "strict regulation." Throughout this transition, numerous insurance companies have faced pressure on their solvency capacity due to transformation demands. Meanwhile, to prevent and mitigate insurance fraud risks, since the 2018 issuance of the Anti-Insurance Fraud Guidelines, regulators have been progressively building fraud risk management standards and anti-fraud technical specifications for the insurance industry. The present moment is a critical test of insurance companies' capital strength and operational capabilities, and risk control capability has become one of the core competitive indicators for all insurers.

Amid the insurtech boom where internet giants and industrial conglomerates are rushing in, three-year-old Zhanlue Data has emerged as a standout, entering from the risk control angle with efficiency and growth speed surpassing many insurtech companies backed by capital giants. Among innovative insurtech companies in the US, some unicorn startups have also emerged that effectively control medical expenditures and improve healthcare services through big data and AI technology, such as Clover Health and Collective Health, which offer considerable inspiration for China's commercial health insurance market.

Unlike risk control service providers in other broad financial sectors, Zhanlue Data positions itself in a vertical track, deeply cultivating the health insurance field and using digital technology and artificial intelligence to serve insurance payers. Zhanlue Data has pioneered a "digital health insurance risk control closed-loop" model that effectively coordinates data integration between policy-based medical insurance and commercial health insurance, connecting operational segments including product design, underwriting, claims processing, and customer service. This enables joint dynamic risk control throughout the entire product lifecycle, providing digital empowerment for product design, rationalized pricing, and refined operations.

Currently, Zhanlue Data has established risk control partnerships with multiple insurance companies, including China Life, PICC, China Taiping, CPIC, China United Insurance, China Continent Insurance, and Hannover Re. Over the past three years, Zhanlue Data's products and services have received considerable industry recognition. The company has become a special affiliate member of LIMRA (Life Insurance Marketing and Research Association) and a governing unit of China Social Security Magazine. In 2019, Zhanlue Data received numerous honors including InsurStar50 — 2018 China Top 50 Insurtech Companies, "Top 10 in 2018 Global Fintech Entrepreneurship Competition" hosted by Tsinghua University's PBC School of Finance Fintech Research Institute, and "2019 China Top 20 Insurance Technology Innovators" awarded by Molecular Lab.

Following this funding round, Zhanlue Data will accelerate its nationwide business expansion and strategic deployment, further develop partnerships with upstream and downstream insurance institutions, and consolidate its leading position in health insurance risk control.

Waterdrop Inc. Completes Over 1 Billion Yuan Series C Funding Round